A Single Center Trial of Donor Site Wound Dressings After Split Thickness Skin Grafting.
NCT ID: NCT06044519
Last Updated: 2023-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
90 participants
INTERVENTIONAL
2022-08-01
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* the effectiveness of different donor site dressings and their adverse outcomes
* the satisfaction of patients with the donor site dressing will be observed. Participants will randomly allocated different types of dressings for split thickness skin graft donor site wound which include alginate hydrocolloid hydrofiber silicon film guaze
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh
NCT04344483
Comparison of Dressing Materials of Donor Site of Split-thickness Skin Graft; Paraffin Mesh Gauze vs Povidone-Iodine Foam at SMBB Institute of Trauma Karachi
NCT07257991
Efficacy of Topical Heparin Spray on Donor Site Wound Healing Time Compared to Conventional Dressing Among Patients Undergoing Split Thickness Skin Grafting
NCT04613336
Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting
NCT01974583
Evaluation of the Use of Minced Skin Grafts for Promoting Donor Site Wound Healing After Split-Thickness Skin Grafting
NCT06488612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
alginate
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
film
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
guaze
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
hydrocolloid
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
hydrofiber
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
silicon
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
different types of dressings
different types of dressings were compared ti see the effectiveness for for STSG donor site wound
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dow University of Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Ruth KM Pfau civil hospital karachi
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Approval/2022/943
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.